Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse publishes preliminary results for the second quarter of 2024 and raises guidance
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse publishes preliminary results for the second quarter of 2024 and raises guidance
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse publishes preliminary results for the second quarter of 2024 and raises guidance
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Publishes Preliminary Financial Figures for the Second Quarter of 2024 and Raises Guidance for 2024
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Publishes Preliminary Financial Figures for the Second Quarter of 2024 and Raises Guidance for 2024
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Publishes Preliminary Financial Figures for the Second Quarter of 2024 and Raises Guidance for 2024
EQS-News: Q2 2024: DWS Increased Revenues and Profit and Raises Outlook for 2024
EQS-News: Q2 2024: DWS Increased Revenues and Profit and Raises Outlook for 2024
EQS-News: Q2 2024: DWS Increased Revenues and Profit and Raises Outlook for 2024
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
EQS-News: Knorr-Bremse Increases Profitability Significantly at the Beginning of the Year
EQS-News: Knorr-Bremse Increases Profitability Significantly at the Beginning of the Year
EQS-News: Knorr-Bremse Increases Profitability Significantly at the Beginning of the Year
EQS-News: Knorr-Bremse increases dividend by 13% to € 1.64
EQS-News: Knorr-Bremse increases dividend by 13% to € 1.64
EQS-News: Knorr-Bremse increases dividend by 13% to € 1.64
EQS-News: Q1 2024: DWS Generates Strong Net Inflows and Reaches New All-Time High for Assets under Management
EQS-News: Q1 2024: DWS Generates Strong Net Inflows and Reaches New All-Time High for Assets under Management
EQS-News: Q1 2024: DWS Generates Strong Net Inflows and Reaches New All-Time High for Assets under Management
EQS-News: Knorr-Bremse Acquires Alstom’s Rail Signalling Technology Business in North America
EQS-News: Knorr-Bremse Acquires Alstom’s Rail Signalling Technology Business in North America
EQS-News: Knorr-Bremse Acquires Alstom’s Rail Signalling Technology Business in North America
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Signs Agreement on the Acquisition of Alstom’s Rail Signalling Technology Business in North America
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Signs Agreement on the Acquisition of Alstom’s Rail Signalling Technology Business in North America
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Signs Agreement on the Acquisition of Alstom’s Rail Signalling Technology Business in North America
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Knorr-Bremse Plans to Raise Dividend by a Significant 13% to € 1.64
EQS-News: Knorr-Bremse Plans to Raise Dividend by a Significant 13% to € 1.64
EQS-News: Knorr-Bremse Plans to Raise Dividend by a Significant 13% to € 1.64
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Knorr-Bremse Aktiengesellschaft: Record Year for Knorr-Bremse: Revenues, Order Intake, and Order Book at Historic Highs, Turnaround Achieved, EBIT Margin Risen
EQS-News: Knorr-Bremse Aktiengesellschaft: Record Year for Knorr-Bremse: Revenues, Order Intake, and Order Book at Historic Highs, Turnaround Achieved, EBIT Margin Risen
EQS-News: Knorr-Bremse Aktiengesellschaft: Record Year for Knorr-Bremse: Revenues, Order Intake, and Order Book at Historic Highs, Turnaround Achieved, EBIT Margin Risen
EQS-News: Knorr-Bremse sells Kiepe Electric to Heramba
EQS-News: Knorr-Bremse sells Kiepe Electric to Heramba
EQS-News: Knorr-Bremse sells Kiepe Electric to Heramba
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
EQS-News: Dermapharm Holding SE publishes  H1 2023 financial report,  confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Strong Growth in Revenues and Profit in H1 2023
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Strong Growth in Revenues and Profit in H1 2023
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Strong Growth in Revenues and Profit in H1 2023